Who is sponsoring NCT03324464?

NCT03324464 is sponsored by Florida State University.

What drugs are being tested in NCT03324464?

Interventions in NCT03324464: Central Executive Training: Working Memory, Central Executive Training: Inhibitory Control.

Is NCT03324464 still recruiting?

NCT03324464 is currently completed. Last updated 7 March 2025.

Last reviewed 2025-03-07 · How we verify

NCT03324464

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Central Executive Training (CET) for ADHD

Completed NA Last updated 7 March 2025

What this trial tests

NA trial testing Central Executive Training: Working Memory in ADHD in 251 participants. Completed in 5 January 2024.

Timeline

1 January 2018

Primary endpoint
31 December 2023

5 January 2024

Quick facts

Lead sponsor	Florida State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	251
Start date	1 January 2018
Primary completion	31 December 2023
Estimated completion	5 January 2024
Sites	1 location across United States

Drugs / interventions tested

Central Executive Training: Working Memory
Central Executive Training: Inhibitory Control

Conditions studied

ADHD — all drugs for ADHD →

Sponsor

Florida State University

Who can join

Adults 8 to 12, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the current project is to assess the efficacy of Central Executive Training (CET) for youth with ADHD. CET is a new, computerized training intervention that targets specific components of the working memory system. Two versions of CET were developed as part of our R34, each targeting a different combinations of executive functions. The final CET protocol reflects the contributions and feedback of a diverse group of caregivers, children with ADHD, and recognized experts in human cognition, ADHD treatment research, randomized control trial (RCT) intervention design methods, serious game theory and task design, cognitive training, and the role of executive dysfunction in ADHD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Does central executive training and/or inhibitory control training improve emotion regulation for children with attention-deficit/hyperactivity disorder? A randomized controlled trial.
Groves NB, Chan ESM, Marsh CL, Gaye F, et al · · 2022 · cited 5× · PMID 36561637 · DOI 10.3389/fpsyt.2022.1034722

Verify or expand the search:

Other recruiting trials for ADHD

Currently open trials in the same condition.

NCT07314333 — A Trial to Assess How Centanafadine Interacts With Stimulants in the Body · Phase 1 · recruiting
NCT07262853 — Dual Executive Function Training Package · NA · recruiting
NCT07291453 — Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits · NA · recruiting
NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
NCT07219810 — Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD · NA · recruiting

Other Florida State University trials

Trials by the same sponsor.

NCT06127914 — Learning Early Infant Feeding Cues · NA · not yet recruiting
NCT06015581 — Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida · NA · not yet recruiting
NCT07467473 — Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression · NA · enrolling by invitation
NCT07221448 — Sodium vs Potassium Education to Improve Vascular Health · NA · recruiting
NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03324464 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Florida State University
Last refreshed: 7 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03324464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing